Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS
· Delayed Price · Currency is USD
0.0499
-0.0101 (-16.83%)
At close: Mar 9, 2026
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $4.45 million as of March 9, 2026. Its market cap has decreased by -54.30% in one year.
Market Cap
4.45M
Enterprise Value
6.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 108.08M to 4.45M, a decrease of -95.88%. That is a compound annual growth rate of -8.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AXIM Biotechnologies | 4.58M |
| GPL Holdings | 4.17M |
| Bioxytran | 4.98M |
| Mosaic ImmunoEngineering | 3.77M |
| Orgenesis | 5.45M |
| Burzynski Research Institute | 3.29M |
| Galera Therapeutics | 3.02M |
| Nymox Pharmaceutical | 6.73M |